Jaydon Mickens

Wide Receiver

Age: 28
Free Agency: 2024 (UFA)
Accrued Seasons: 5
  • 2022 Salary Cap Charge: $0 (0.00% of cap)
  • 2022 Cash Payout: $0 (0.00% of spending)
  • 2022 Cash to Cap Ratio: 0
  • Contract Value: $1,080,000 ($1,080,000 APY)
  • Fully Guaranteed Money: $0
  • Contract Ranking: 143/309 at WR

Current Contract

(SFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryCap
Number
Cap %
Dead Money & Cap Savings
202329$1,080,000$940,0000.4%
Total$1,080,000$940,000

Cash Flows

- fully earned money
- unearned or partially earned money
$1.1M
2023
Cash Due$1,080,000
Running Cash$1,080,000
Career Earnings: $2,444,393
Career APY: $349,199
Potential Earnings: $2,440,922
Total Guarantees: $0
Largest Cash Payment: $1,080,000 (2023)
Largest Cap Number: $940,000 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RaidersSFATerminated20171$465,000$465,000$0$00.0%$0
JaguarsPracticeRenegotiated20171$122,400$122,400$0$00.0%$0
JaguarsSFAExpired20172$1,020,000$510,000$0$741,35272.7%$370,676
PanthersSFATerminated20191$645,000$645,000$0$00.0%$0
BuccaneersPracticeRenegotiated20191$136,000$136,000$0$00.0%$0
BuccaneersSFATerminated20192$1,305,000$652,500$0$37,9412.9%$37,941
BuccaneersSFATerminated20202$1,670,000$835,000$0$00.0%$0
BuccaneersPracticeRenegotiated20201$142,800$142,800$0$00.0%$0
BuccaneersSFATerminated20202$1,670,000$835,000$0$44,1182.6%$44,118
BuccaneersPracticeRenegotiated20211$293,000$293,000$0$00.0%$0
BuccaneersPracticeElevated20211$252,000$252,000$0$00.0%$0
BuccaneersSFATerminated20211$990,000$990,000$0$00.0%$0
BuccaneersPracticeTerminated20211$252,000$252,000$0$00.0%$0
JaguarsSFAExpired20211$990,000$990,000$0$358,61136.2%$358,611
GiantsPracticeExpired20221$277,200$277,200$0$61,60022.2%$61,600
GiantsSFAActive20231$1,080,000$1,080,000$0$00.0%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Raiders1$165,242$165,242$117,3000.0%$47,9420.0%
Jaguars3$1,128,763$376,254$1,050,5190.0%$28,8000.0%
Panthers0$0$0$00.0%$00.0%
Buccaneers2$1,088,788$544,394$82,0590.0%$967,8400.0%
Giants1$61,600$61,600$61,6000.0%$00.0%

Season History

YearTeamBase SalaryCap
Number
Cap %Cash Paid
2016Raiders$117,300$117,3000.1%$117,300
2017Jaguars$465,000$300,8820.1%$300,882
2018Jaguars$555,000$440,4700.2%$440,470
2019Buccaneers$645,000$37,9410.0%$37,941
2020Buccaneers$750,000$44,1180.0%$44,118
2021Jaguars$990,000$309,1670.1%$358,611
2022Giants$277,200$61,6000.0%$61,600
2023Giants$1,080,000$940,0000.4%$1,080,000
Total$4,879,500$2,251,478$2,440,922
Dead Money History
TeamYearCap ChargeCash Paid
Raiders2016$2,333$7,000
Raiders2017$4,667$0
Jaguars2017$28,800$28,800
Raiders2017$40,942$40,942
Buccaneers2019$8,000$8,000
Buccaneers2020$25,200$25,200
Buccaneers2020$573,529$573,529
Buccaneers2021$55,000$55,000
Buccaneers2021$236,111$275,000
Buccaneers2021$70,000$70,000
Total$1,044,582$1,083,471

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2017101609.4%32.6%000.0056613.2200
201861000.3%20.7%000.00000.0010
20191002.2%2.2%000.00000.0000
202010007.0%27.2%000.007588.3000
202111102.2%26.9%000.002105.0000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$0$0
Injury Adjusted$0$0
test
OTC Valuation $4.5M $8.9M $13.4M $17.8M $22.3M APY $5M $10M $15M $20M $25M $9,108,000 $6,771,499

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.